Envista (NYSE:NVST) Issues Earnings Results, Beats Expectations By $0.01 EPS

Envista (NYSE:NVST) released its earnings results on Wednesday. The company reported $0.24 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.01, Zacks reports. Envista had a positive return on equity of 3.76% and a negative net margin of 53.42%. Envista updated its FY 2025 guidance to 0.950-1.050 EPS.

Envista Stock Up 2.2 %

Shares of NYSE:NVST traded up $0.45 during trading on Wednesday, hitting $20.58. 4,921,988 shares of the company were exchanged, compared to its average volume of 2,076,956. The stock has a market cap of $3.54 billion, a price-to-earnings ratio of -2.65, a P/E/G ratio of 1.82 and a beta of 1.34. The company has a current ratio of 2.08, a quick ratio of 1.77 and a debt-to-equity ratio of 0.42. Envista has a fifty-two week low of $15.15 and a fifty-two week high of $24.79. The firm has a fifty day moving average price of $20.00 and a two-hundred day moving average price of $19.09.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. Robert W. Baird increased their price target on shares of Envista from $17.00 to $22.00 and gave the company a “neutral” rating in a research report on Thursday, October 31st. Mizuho assumed coverage on shares of Envista in a research report on Wednesday, December 4th. They set an “underperform” rating and a $20.00 price target on the stock. Leerink Partners raised shares of Envista from an “underperform” rating to a “market perform” rating and boosted their price target for the company from $16.00 to $23.00 in a report on Thursday, October 31st. Jefferies Financial Group lifted their target price on Envista from $20.00 to $22.00 and gave the stock a “hold” rating in a report on Thursday, January 23rd. Finally, Needham & Company LLC restated a “hold” rating on shares of Envista in a report on Thursday, October 31st. Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat.com, Envista currently has an average rating of “Hold” and a consensus target price of $20.21.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.